Skip to main content

Table 1 Baseline characteristics of heart transplant recipients and healthy control subjects

From: Blood volume and hemoglobin mass in long-term heart transplant recipients with and without Anemia

 

Group

p

HTX

CON

Sex (F, M, total n)

7 F, 29 M, 36

5 F, 41 M, 46

 

Age (yrs)

51.6 ± 15.3

52.1 ± 13.4

0.878

Height (cm)

177.3 ± 8.0

178.4 ± 6.4

0.531

Weight (kg)

83.9 ± 18.1

83.0 ± 10.7

0.773

BMI (kg/m2)

26.6 ± 5.0

26.1 ± 3.6

0.676

BSA (m2)

2.0 ± 0.2

2.0 ± 0.1

0.944

Heart rate (/min)

84.7 ± 10.9

–

 

Mean arterial pressure (mmHg)

104 ± 10.7 (n = 32)

–

 

Ejection fraction (%), Simpson’s rule

59.7 ± 6.7 (n = 29)

–

 

E/e’ mean

9.2 ± 4.1 (n = 31)

  

proBNP (pg/ml)

555 ± 525 (n = 32)

–

 

Years since heart transplantation

6.3 ± 4.3

–

 

Cause for HTX

 Ischemic CM, n (%)

9 (25)

–

 

 Dilatative CM, n (%)

20 (56)

–

 

 Myocarditis, n (%)

5 (14)

–

 

 Other, n (%)

2 (5)

–

 

Medication in HTX

 Calciumchannel blocker

19 (53)

  

 Beta-blocker

8 (22)

–

 

 Ivabradine

1 (3)

–

 

 ACE-inhibitor

15 (42)

–

 

 AT-1 antagonist

9 (25)

–

 

 Diuretic

19 (53)

–

 

 Loop diuretic

16 (44)

–

 

 Thiazide

4 (11)

–

 

 Iron supplementation

3 (8)

–

 

 Glucocorticoid

3 (8)

–

 

Immunosuppression

 Everolimus / Cyclosporine

18 (50)

–

 

 Everolimus / Tacrolimus

7 (19)

–

 

 MMF / Cyclosporine

7 (19)

–

 

 MMF / Tacrolimus

4 (11)

–

 
  1. Footnote: Data presented as mean ± SD. HTX = heart transplant recipients. CON = control subjects. BMI = body mass index. BSA = body surface area. proBNP = pro – brain natriuretic peptide (normal range < 125 pg/ml). CM = cardiomyopathy. ACE = angiotensin converting enzyme. AT-1 = angiotensin 1. MMF = mycophenolate mofetil